AI
CLB icon

Ariel Investments’s Core Laboratories CLB Stock Holding History

Ariel Investments’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221M Sell
13,170,388
-490,612
-4% -$8.78M 2.48% 15
2025
Q4 		$219M Sell
13,661,000
-112,568
-0.8% -$1.68M 2.37% 16
2025
Q3 		$170M Buy
13,773,568
+797,105
+6% +$9.34M 1.82% 24
2025
Q2 		$149M Buy
12,976,463
+2,634,438
+25% +$31.2M 1.69% 28
2025
Q1 		$155M Buy
10,342,025
+709,455
+7% +$11.9M 1.82% 28
2024
Q4 		$167M Sell
9,632,570
-412,686
-4% -$7.96M 1.78% 26
2024
Q3 		$186M Sell
10,045,256
-247,040
-2% -$4.96M 1.9% 23
2024
Q2 		$209M Sell
10,292,296
-533,361
-5% -$9.44M 2.26% 10
2024
Q1 		$185M Buy
10,825,657
+1,837,258
+20% +$28.9M 1.82% 22
2023
Q4 		$159M Sell
8,988,399
-75,319
-0.8% -$1.52M 1.58% 31
2023
Q3 		$218M Sell
9,063,718
-568,005
-6% -$13.9M 2.3% 10
2023
Q2 		$224M Buy
9,631,723
+122,495
+1% +$2.77M 2.12% 12
2023
Q1 		$210M Sell
9,509,228
-193,894
-2% -$4.54M 2.01% 16
2022
Q4 		$197M Sell
9,703,122
-62,193
-0.6% -$1.21M 2% 18
2022
Q3 		$132M Buy
9,765,315
+581,090
+6% +$9.79M 1.45% 31
2022
Q2 		$182M Buy
9,184,225
+985,681
+12% +$26.2M 1.82% 19
2022
Q1 		$259M Buy
8,198,544
+394,237
+5% +$11.1M 2.3% 13
2021
Q4 		$174M Buy
7,804,307
+3,544,659
+83% +$92.4M 1.47% 27
2021
Q3 		$118M Buy
4,259,648
+678,856
+19% +$20.7M 1.08% 36
2021
Q2 		$139M Sell
3,580,792
-208,150
-5% -$7.46M 1.31% 28
2021
Q1 		$109M Sell
3,788,942
-732,059
-16% -$25M 1.07% 34
2020
Q4 		$120M Buy
4,521,001
+1,340,488
+42% +$27.4M 1.35% 25
2020
Q3 		$48.5M Buy
3,180,513
+1,095,980
+53% +$23M 0.7% 49
2020
Q2 		$42.4M Buy
+2,084,533
New +$37.4M 0.65% 48
2019
Q3 		– Sell
-448,977
Closed -$23.5M – 145
2019
Q2 		$23.5M Sell
448,977
-4,736
-1% -$278K 0.29% 80
2019
Q1 		$31.3M Sell
453,713
-1,560
-0.3% -$105K 0.39% 74
2018
Q4 		$27.2M Sell
455,273
-45,087
-9% -$3.89M 0.38% 73
2018
Q3 		$58M Buy
500,360
+9,445
+2% +$1.07M 0.64% 58
2018
Q2 		$62M Sell
490,915
-907
-0.2% -$110K 0.7% 56
2018
Q1 		$53.2M Sell
491,822
-2,278
-0.5% -$252K 0.61% 60
2017
Q4 		$54.1M Buy
494,100
+41,619
+9% +$4.15M 0.61% 59
2017
Q3 		$44.7M Buy
452,481
+129,098
+40% +$12.5M 0.52% 62
2017
Q2 		$32.7M Buy
323,383
+11,237
+4% +$1.21M 0.39% 70
2017
Q1 		$36.1M Buy
312,146
+37,802
+14% +$4.39M 0.42% 68
2016
Q4 		$32.9M Buy
274,344
+11,720
+4% +$1.3M 0.39% 71
2016
Q3 		$29.5M Buy
262,624
+12,647
+5% +$1.46M 0.36% 72
2016
Q2 		$31M Sell
249,977
-55,492
-18% -$6.7M 0.39% 73
2016
Q1 		$34.3M Buy
305,469
+23,320
+8% +$2.42M 0.41% 68
2015
Q4 		$30.7M Buy
282,149
+18,177
+7% +$2.08M 0.37% 73
2015
Q3 		$26.3M Buy
263,972
+26,883
+11% +$2.92M 0.33% 78
2015
Q2 		$27M Buy
237,089
+29,572
+14% +$3.59M 0.3% 77
2015
Q1 		$21.7M Buy
207,517
+151,482
+270% +$16.1M 0.24% 86
2014
Q4 		$6.74M Buy
56,035
+13,438
+32% +$1.77M 0.08% 140
2014
Q3 		$6.23M Buy
42,597
+22,743
+115% +$3.51M 0.08% 137
2014
Q2 		$3.32M Buy
+19,854
New +$3.53M 0.04% 161

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ariel Investments's CLB Position: Q1 2026 in Review

Ariel Investments reduced its Core Laboratories (CLB) stake by 3.6% in Q1 2026, selling an estimated $8.78M and leaving 13,170,388 shares worth $221M. The position accounts for 2.48% of the portfolio, ranked #15.

Ariel Investments first reported a position in CLB in Q2 2014 and has held it in 45 quarters since. The position peaked at $259M in Q1 2022. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Ariel Investments held 13,170,388 shares of Core Laboratories worth $221M as of Q1 2026.
  • Ariel Investments sold 490,612 Core Laboratories shares in Q1 2026, an estimated $8.78M.
  • Core Laboratories made up 2.48% of Ariel Investments's portfolio in Q1 2026, its #15 holding.
  • Ariel Investments first reported a position in Core Laboratories in Q2 2014 and has held it in 45 quarters since.
  • Ariel Investments's Core Laboratories position peaked at $259M in Q1 2022.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Ariel Investments's 13F filing for Q1 2026, filed 14 May 2026.